Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND)
Kurapati KR, Atluri VS, Samikkannu T, Nair MP
PloS one · 73 citas
Etiquetas de revisión
Solo mecanismosDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Estudio in vitro o de mecanismos (clasificado por nuestro filtro de IA)
- Estudiado en
- Células o muestras de laboratorio
- Resultado principal
- Solo mecanismos
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- National Institute of Mental Health
- Gobierno
- National Institute on Drug Abuse
- Gobierno
- NIMH NIH HHS
- Gobierno
- NIDA NIH HHS
- Subvenciones
- National Institute on Drug Abuse (1R01-DA027049); National Institute on Drug Abuse (1R37DA025576); National Institute on Drug Abuse (R01DA021537); National Institute on Drug Abuse (R37DA025576); National Institute of Mental Health (R01 MH085259); National Institute on Drug Abuse (5R01DA021537); National Institute of Mental Health (1R01MH085259); National Institute on Drug Abuse (R01-DA027049)
Según 4 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2013-10-16 · PLoS One · vol. 8 · número 10 · pág. e77624
- Editorial
- Public Library of Science
- Citado
- 129 citas · más que el 100% de estudios similares · 28.3× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 75 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Phytochemicals and Medicinal Plants · Medicinal Plants and Neuroprotection
- Palabras clave
- Withania somnifera, Neurocognitive, Toxicity, Neurotoxicity, Biology, Medicine, Pharmacology, Neuroscience, Pathology, Internal medicine, Cognition
- MeSH
- neurons, dendrites, cell line, humans, withania, hiv infections, nervous system diseases, hydro-lyases, peptide fragments, ppar gamma, neuroprotective agents, plant extracts, chromatography, high pressure liquid, cell survival, mass spectrometry, amyloid beta-peptides
4 autores
- Kesava Rao Venkata Kurapati🇺🇸Florida International University
- Venkata Subba Rao Atluri🇺🇸Florida International University
- Thangavel Samikkannu🇺🇸Florida International University
- Madhavan Nair🇺🇸 · autor de correspondenciaFlorida International University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Alzheimer's disease (AD) is characterized by progressive dysfunction of memory and higher cognitive functions with abnormal accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles throughout cortical and limbic brain regions. At present no curative treatment is available, and research focuses on drugs for slowing disease progression or providing prophylaxis. Withania somnifera (WS) also known as 'ashwagandha' is used widely in Ayurvedic medicine as a nerve tonic and memory enhancer. However, there is a paucity of data on the potential neuroprotective effects of W.somnifera against β-Amyloid (1-42)-induced neuropathogenesis. In the present study, we have tested the neuroprotective effects of methanol:Chloroform (3:1) extract of ashwagandha against β-amyloid induced toxicity and HIV-1Ba-L (clade B) infection using a human neuronal SK-N-MC cell line. Our results showed that β-amyloid induced cytotoxic effects in SK-N-MC cells as shown by decreased cell growth when tested individually. Also, confocal microscopic analysis showed decreased spine density, loss of spines and decreased dendrite diameter, total dendrite and spine area in clade B infected SK-N-MC cells compared to uninfected cells. However, when ashwagandha was added to β-amyloid treated and HIV-1 infected samples, the toxic effects were neutralized. Further, the MTT cell viability assays and the peroxisome proliferator-activated receptor-γ (PPARγ) levels supported these observations indicating the neuroprotective effect of WS root extract against β-amyloid and HIV-1Ba-L (clade B) induced neuro-pathogenesis.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.